Cargando…

Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?

Cryptogenic stroke and transient ischemic attack (TIA) account for approximately one-third of stroke patients [1]. Paroxys-mal atrial fibrillation (PAF) has been suggested as a major etiology of these cryptogenic strokes [2, 3]. PAF can be difficult to diagnose because it is intermittent, often brie...

Descripción completa

Detalles Bibliográficos
Autores principales: Montalvo, Mayra, Ali, Rushna, Silver, Brian, Khan, Muhib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897003/
https://www.ncbi.nlm.nih.gov/pubmed/27347225
http://dx.doi.org/10.2174/1874192401610010089
_version_ 1782436064956252160
author Montalvo, Mayra
Ali, Rushna
Silver, Brian
Khan, Muhib
author_facet Montalvo, Mayra
Ali, Rushna
Silver, Brian
Khan, Muhib
author_sort Montalvo, Mayra
collection PubMed
description Cryptogenic stroke and transient ischemic attack (TIA) account for approximately one-third of stroke patients [1]. Paroxys-mal atrial fibrillation (PAF) has been suggested as a major etiology of these cryptogenic strokes [2, 3]. PAF can be difficult to diagnose because it is intermittent, often brief, and asymptomatic. PAF might be more prevalent than persistent atrial fibrillation in stroke and TIA patients, especially in younger populations [4, 5]. In patients with atrial fibrillation, anticoagulation provides significant risk reduction [6]. A new generation of oral anticoagulants has been approved for non-valvular atrial fibrillation, providing a variety of therapeutic options for patients with atrial fibrillation and risk of stroke [7]. Prior practice included an admission electrocardiogram (ECG) and continuous telemetry monitoring while in hospital [8]. However, this approach can lead to under-detection of brief asymptomatic events, which can occur at variable intervals, often outside of the hospital setting. Technological advancements have led to devices that can monitor cardiac rhythms outside of the hospital for longer durations resulting in higher yield of detection of atrial fibrillation events. Moreover, recent studies show that the normal monitoring time for arrhythmias may be shorter than ideal in order to detect atrial fibrillation, and increasing this interval could significantly improve detection of atrial fibrillation in these patients [9, 10]. The aim of this study is to review the literature in order to define what subgroup of patients, with what methodologies, and for how long monitoring for atrial fibrillation should occur in patients presenting with cryptogenic stroke.
format Online
Article
Text
id pubmed-4897003
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-48970032016-06-24 Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long? Montalvo, Mayra Ali, Rushna Silver, Brian Khan, Muhib Open Cardiovasc Med J Article Cryptogenic stroke and transient ischemic attack (TIA) account for approximately one-third of stroke patients [1]. Paroxys-mal atrial fibrillation (PAF) has been suggested as a major etiology of these cryptogenic strokes [2, 3]. PAF can be difficult to diagnose because it is intermittent, often brief, and asymptomatic. PAF might be more prevalent than persistent atrial fibrillation in stroke and TIA patients, especially in younger populations [4, 5]. In patients with atrial fibrillation, anticoagulation provides significant risk reduction [6]. A new generation of oral anticoagulants has been approved for non-valvular atrial fibrillation, providing a variety of therapeutic options for patients with atrial fibrillation and risk of stroke [7]. Prior practice included an admission electrocardiogram (ECG) and continuous telemetry monitoring while in hospital [8]. However, this approach can lead to under-detection of brief asymptomatic events, which can occur at variable intervals, often outside of the hospital setting. Technological advancements have led to devices that can monitor cardiac rhythms outside of the hospital for longer durations resulting in higher yield of detection of atrial fibrillation events. Moreover, recent studies show that the normal monitoring time for arrhythmias may be shorter than ideal in order to detect atrial fibrillation, and increasing this interval could significantly improve detection of atrial fibrillation in these patients [9, 10]. The aim of this study is to review the literature in order to define what subgroup of patients, with what methodologies, and for how long monitoring for atrial fibrillation should occur in patients presenting with cryptogenic stroke. Bentham Open 2016-05-27 /pmc/articles/PMC4897003/ /pubmed/27347225 http://dx.doi.org/10.2174/1874192401610010089 Text en © Montalvo et al.; Licensee Bentham Open. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Montalvo, Mayra
Ali, Rushna
Silver, Brian
Khan, Muhib
Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?
title Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?
title_full Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?
title_fullStr Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?
title_full_unstemmed Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?
title_short Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?
title_sort long-term arrhythmia monitoring in cryptogenic stroke: who, how, and for how long?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897003/
https://www.ncbi.nlm.nih.gov/pubmed/27347225
http://dx.doi.org/10.2174/1874192401610010089
work_keys_str_mv AT montalvomayra longtermarrhythmiamonitoringincryptogenicstrokewhohowandforhowlong
AT alirushna longtermarrhythmiamonitoringincryptogenicstrokewhohowandforhowlong
AT silverbrian longtermarrhythmiamonitoringincryptogenicstrokewhohowandforhowlong
AT khanmuhib longtermarrhythmiamonitoringincryptogenicstrokewhohowandforhowlong